baber/WOPTO huggingface dataset:
Patent IL-120423-A0 (IL)
Title: Advanced set top terminal for cable television delivery systems
IPC: H04H20/78
Filed: 1997-03-11
Abstract: A novel advanced set top terminal capable of digital decompression, menu generation, interactivity and other advanced functional capabilities for use in a television program delivery system (200) is described. The invention relates to methods and apparatus for upgrading existing set top terminals (220) to provide menu generation capability and advanced functional capabilities. The invention is particularly useful in television program delivery systems (200) with hundreds of channels of programming, providing (i) menu driven program selection through the addition of an upgrade module (300) or menu generation card and (ii) advanced functional capabilities using a set of hardware upgrades (e.g., 130) and/or an expansion card. Specifically, the invention is an upgradeable system that supports advanced set top functionality through the use of internal software, hardware upgrades, an upgrade module and/or expansion cards. The upgraded hardware generally includes a microprocessor, various input/output ports (e.g., 308), processing circuitry (e.g., 108) and memory (e.g., 116). The invention results in an upgraded set top terminal that supports: menu generation; picture-on-picture displays; program catalogue services; interactive services; telephone caller identification; digital audio reception; VCR control; HDTV reception; and backyard satellite system interoperability, among other features and capabilities.
Patent IL-123042-A0 (IL)
Title: Procedure for drying silicon
IPC: H01L21/304
Filed: 1996-08-09
Abstract: A method of drying a substrate surface (1), comprising:   dipping the substrate into a liquid bath (2); separating the substrate from the liquid bath (2), whereby the liquid of the liquid bath (2) comprises an aqueous HF solution (3), the substrate surface being hydrophobic upon separation from the liquid bath, the substrate being separated from the bath at a rate that permits the bath liquid to drain from the hydrophobic surface of the substrate to produce a dry substrate; and that a gas comprising an O2/O3 mixture that forms a hydrophilic surface on the substrate is directed over the surface of the substrate (1) after separating the substrate (1) from the liquid bath.   <IMAGE>
Patent IL-123721-A0 (IL)
Title: Imidazole derivatives having affinity for alpha 2 receptor activity
IPC: A61P27/06
Filed: 1996-10-02
Abstract: Imidazole derivatives of formula (I)wherein n is 0 or 1, R1 is hydrogen or C1-C4-alkyl, R2 is hydrogen or R2 and R3 together form a double bond, R3 is hydrogen or C1-C4-alkyl or R2 and R3 together form a double bond, R4 is hydrogen, C1-C4-alkyl, hydroxy or C1-C4-alkoxy, R5 is hydrogen or C1-C4-alkyl or R4 and R5 together with the carbon atom to which they are attached form a carbonyl group, R6, R7 and R8 are each the same or different and are independently hydrogen, C1-C4-alkyl or C2-C4-alkenyl, C3-C7-cycloalkyl, hydroxy, C1-C4-alkoxy, C1-C4-hydroxyalkyl, thiol, C1-4-alkylthio, C1-4-alkylthiol, halogen, trifluoromethyl, nitro or optionally substituted amino, X is -CHR9-(CHR10)m-, m is 0 or 1, and R9 and R10 are each the same or different and are independently hydrogen or C1-C4-alkyl; or a pharmaceutically acceptable ester or salt thereof, their preparation, use and pharmaceutical compositions comprising them are described. The compounds have affinity for alpha2 receptors and are useful e.g. in the treatment of hypertension, glaucoma, chronic or acute pain, migraine, diarrhea, common cold, ischemia, addiction to chemical substances, anxiety, especially preoperative anxiety and different neurological, musculoskeletal, psychiatric and cognition disorders or as adjuncts to anesthesia.
Patent IL-127507-A0 (IL)
Title: Method of manufacturing whisker-reinforced ceramics
IPC: C04B35/80
Filed: 1998-12-10
Abstract: The present invention relates to a method of making a whisker reinforced ceramic body by hot pressing a preform to a disk, cutting the disk into blanks and grinding the blanks to bodies of desired shape and dimension. According to the invention the preform is prepared by   dispersing 10-50 % by volume of a ceramic powder mixture containing conventional sintering aids and/or grain growth inhibitors in water or an organic solvent   adding 1-15 wt-% starch to the dispersion   pouring the dispersion into a mould with desired shape heating the suspension to 50-100  DEG C for 2-4 hours during covering the mould to avoid water evaporation to form a preform   removing the preform from the mould and   presintering the preform in air for 10 h at about 600  DEG C.   <IMAGE>
Patent IL-128691-A0 (IL)
Title: Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
IPC: A61K31/4725
Filed: 1997-09-11
Abstract: This invention is directed to benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
Patent IL-134183-A0 (IL)
Title: Process for the production of 2,3,5- trimethylhydroquinone diesters
IPC: C07C69/017
Filed: 2000-01-24
Abstract: In the preparation of 2,3,5-trimethyl-hydroquinone diesters (I) by catalytic acylation of keto-isophorone (II), the acylating agent is a carboxylic anhydride containing a 1-4C alkyl residue, the reaction solution is cooled to -10 to 35 (preferably 0-30) degrees C, the crystallized (I) is filtered off and the filtrate is recycled to the acylation.  In the preparation of 2,3,5-trimethyl-hydroquinone diesters (I) by catalytic acylation of keto-isophorone (II), the acylating agent is a carboxylic anhydride containing a 1-4C alkyl residue, the reaction solution is cooled to -10 to 35 (preferably 0-30) degrees C (optionally after distilling off part of the obtained carboxylic acid (III)), the crystallized (I) is filtered off and the filtrate is recycled to the acylation (optionally after distilling off part of (III) and/or discarding part of the filtrate).
Patent IL-146440-A0 (IL)
Title: Energy-activated compositions for controlled sustained release of gas
IPC: A01N59/00
Filed: 2000-04-20
Abstract: A composition for energy-controlled generation and release of at least one gas, which includes an energy-activated catalyst capable of being activated by electromagnetic energy, and a solid or a liquid containing anions capable of being oxidized by the activated catalyst or reacted with species generated during activation of the catalyst to generate at least one gas. The composition, when exposed to electromagnetic energy, is capable of generating and releasing the gas after activation of the catalyst and oxidation or reaction of the anions.
Patent IL-149259-A0 (IL)
Title: Beverage dispensing and beverage containers
IPC: A23F5/24
Filed: 2000-11-03
Abstract: A container contains coffee, tea or a soft drink saturated with an inert gas and, if necessary or desired, a foam-retaining agent. Alternatively, a bulk container includes coffee, tea or a soft drink and, if necessary or desired, a foam-retaining agent, in association with means for dispensing the soft drink, and means for introducing an inert gas on dispensing. <??>By means of the invention, a non-alcoholic drink is dispensed with a creamy head.
Patent IL-151408-A0 (IL)
Title: Use of insulin for the treatment of cartilagenous disorders
IPC: A61K38/30
Filed: 2002-08-21
Abstract: The present invention relates to methods for the treatment and repair of cartilage, including cartilage damaged by injury or cartilaginous disorders, including arthritis, comprising the administration of insulin and/or insulin variants. Optionally, the administration may be in combination with a cartilage agent (e.g., peptide growth factor, catabolism antagonist, osteo-, synovial, anti-inflammatory factor), in an extended- or sustained-release form. Alternatively, the method provides for the treatment and repair of cartilage damaged by injury or cartilaginous disorders comprising the administration of insulin and/or insulin in combination with standard surgical techniques. Alternatively, the method provides for the treatment and repair of cartilage damaged by injury or cartilaginous disorders comprising the administration of chondrocytes previously treated with an effective amount of insulin and/or insulin variant.
Patent IL-151477-A0 (IL)
Title: Medical diagnostic system
IPC: G01N33/483
Filed: 2001-03-05
Abstract: A system for conducting a plurality of different medical diagnostic tests comprises a hand-held portable self contained instrument for engaging a disposable test cell containing a fluid to be tested. The instrument performs a diagnostic test selected from the plurality of tests upon the fluid within the test cell, the test being selected by the instrument based upon identification information obtained from the test cell. A disposable, single use test cell is provided for receiving fluid to be diagnostically tested. The test cell includes identification information indicative of a particular test to be performed upon the fluid, the test cell being sized and shaped for engagement by the instrument.
Patent IL-153639-A0 (IL)
Title: 9-substituted minocycline compounds
IPC: C07C275/30
Filed: 2001-06-29
Abstract: The present invention pertains, at least in part, to novel 9- substituted minocycline compounds. These minocycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
Patent IL-153908-A0 (IL)
Title: PHARMACEUTICAL COMPOSITIONS CONTAINING 2alpha-METHYL-19-NOR-20(S)-1alpha, 25-DIHYDROXYVITAMIN D3
IPC: A61K31/56
Filed: 2001-07-10
Abstract: This invention provides pharmaceutical uses for 2alpha-methyl-19-nor-20(S)-1alpha,25-dihydroxyvitamin D<SUB>3</SUB>. This compound is characterized by high bone calcium mobilization activity demonstrating preferential activity on bone. This results in a novel therapeutic agent for the treatment of diseases where bone formation is desired, particularly osteoporosis. This compound also exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis. This compound also increases both breaking strength and crushing strength of bones evidencing use in conjunction with bone replacement surgery such as hip and knee replacements.
Patent IL-179657-A0 (IL)
Title: Injection device
IPC: A61M5/32
Filed: 2006-11-28
Abstract: An injection device (110) is described having a housing (112) and a cap (130). The injection device (110) houses a syringe (114) having a needle (118) which is sealed by a boot (120). The cap (130) is arranged so that the boot (120) can be connected to the cap (130) simply, but cannot be removed from the cap (130). The housing (112) and cap (130) are arranged so that upon rotation of the cap (130), the cap (130) is moved axially away from the housing (112) and the boot (120) is removed from the syringe (114). The injection device is simple to use and manufacture.
Patent IL-192365-A0 (IL)
Title: Method, system and device for realizing group-sending message service
Filed: 2008-06-22
Abstract: A method for realizing a group-sending message service of the present invention is provided. The address information of a plurality of recipients assigned by a user is carried in a message body, and then a message application server finishes analyzing a group-sending flow directed to a plurality of users. The present invention further provides an apparatus for realizing the method and a system thereof. Since it needs performing communication between terminals and the server merely once, the network resource is saved. Because the group-sending address list is edited into the message body, it is more flexible for a user to assign destination recipients without being limited by the forms and numbers of recipients, and enriches the function of group-sending message service. Further, a provider can even supply a group-sending message to customers as a separate service, thus having a desirable commercial value.
Patent RO-133105-A0 (RO)
Title: Device and method for maintaining physical health and stimulating creativity
Inventor: NICOLAU MIHAELA ALEXANDRA
IPC: G06Q10/00
Filed: 2018-09-07
Abstract: The invention relates to a method for maintaining physical health by stimulating the natural inclination to take exercise and to a device for carrying out the same. The claimed method comprises a first stage of monitoring the user while performing physical activity and recording the acceleration values in three axes, said values being meant to be used by an algorithm for determining the user's activity and also recording the values of physiological parameters to be subsequently used by another algorithm for determining the emotional state, in relation to which the user is reminded to take exercise, followed by a stage of detecting and acquiring the user's movements and determining, by means of another algorithm, the 2D coordinates of the user's articulations and calculating a set of movement parameters used for composing a melody in harmony with the user's affective function. The claimed device comprises a base unit (UB), having a processor (P), a memory (M), a video camera (CV) and an audio system (SA), which communicates by Bluetooth Low Energy protocol with a wearable equipment (EP) which contains a triple axis accelerometer (A), a conductance sensor (SC), a temperature sensor (ST) and a pulse oximeter sensor (SPO).
Patent AP-2001002067-A0 (AP)
Title: New pharmaceutical uses for nos inhibitors.
Inventor: LOWE III JOHN ADAMS
IPC: A61K31/46
Filed: 1999-08-05
Abstract: The present invention relates to new pharmaceutical uses for compounds that exhibit activity as nitric oxide synthase (NOS) inhibitors. Specifically, it relates to the use of NOS inhibitors, particularly selective neuronal NOS (N-NOS) inhibitors (a) alone or in combination with another active agent for the treatment of psoriasis; (b) in combination with an antiiflammatory agent for the treatment of inflammatory disorders; (c) in combination with a narcotic analgesic (e.g., opiates such as morphine or demerol) for the treatment of pain; (d) alone or in combination with other active agents for the enhancement of cognition; and (e) alone or in combination with other active agents for the treatment of sleep disorders such as apnea, narcolepsy and insomnia.
Patent IE-910332-A1 (IE)
Title: Surgical Reamer
Inventor: BORZONE ROCCO R
IPC: A61B17/16
Filed: 1991-01-31
Abstract: The cutting head 10 for a surgical reamer has a leading end 12 for insertion into a bone canal 60 and a trailing end 13 for attachment to a drive shaft 16. The cutting head has a cutting surface formed about an axis of rotation of the cutting head. The cutting surface is formed by the rotation of the cutting edges on a plurality of flutes 20 spaced around the axis of rotation. Each cutting edge has a first portion 26 spaced a predetermined radial distance from the axis of rotation at the tip portion 22 and terminates at a terminating point 30 which is at a greater radial distance from the axis of rotation than the starting point 28. The cutting edge on each flute 20 has a second portion 32 having a starting point 34 at the trailing end 24 of the cutting head 10 which is at a second predetermined radial distance from the axis of rotation. The second portion 32 extends axially towards the tip portion 22 and terminates at a point 36 at a greater radial distance from the axis of rotation than the starting point 34 thereof. A third curved portion 38 starts at the terminating point 30 of the first portion 26 and terminates at the terminating point 36 of the second portion 32 and intersects the first and second portions tangentially. <IMAGE>
Patent IE-20000400-A1 (IE)
Title: Incinerator System and Method for Bulk Refuse
Inventor: SR JOHN N BASIC
IPC: F23G5/00
Filed: 1990-10-11
Abstract: An incinerator for bulk refuse has an inlet (231) for receiving bulk refuse and a floor (33) located at a level below the inlet opening.  A grate (234) is located immediately adjacent the inlet opening (231) and above the level of the floor (33).  Accordingly, newly introduced bulk refuse is initially contained on the grate (34), but falls through openings in the grate onto the floor where combustion is completed.  Preferably, the grate is sized such material introduced into the incinerator falls through the grate onto the floor before the majority of the fixed hydrocarbons in the bulk refuse have burnt.  The grate arrangement is advantageous in allowing drying of wet material and in preventing high energy materials burning at high temperature on the floor of the incinerator and thereby causing slagging.  <Figure 16>
Patent LU-88474-A1 (LU)
Inventor: KIENLEN DOMINIQUE
IPC: E06B3/54
Filed: 1994-04-06
Abstract: The invention relates to a system for sealing between the frames of a framework for a facade of the shutter-wall type, in which the gaps (5) between adjacent glazing elements (panes of glass) (3,4) are open to the surrounding atmosphere and allow the natural elements (bad weather) to penetrate inside the framework. According to the invention, this system comprises, in combination, a primary seal (6) made of elastomeric material, positioned vertically and set back inside the building relative to the facade, and a secondary seal (7), also made of elastomeric material, a first part (7b) of which forms a flap which extends horizontally, between two crossmembers of superimposed frames (2), in the direction of the facade, between the primary seal (6) and the facade, whereas a second part (7a), joined to the first part and rising perpendicularly to the latter, extends to the rear of the primary seal (6), relative to the facade, and is inserted between facing vertical surfaces of the two adjacent frames. <IMAGE>
Patent MA-18534-A1 (MA)
Inventor: DONALD W G
IPC: C07C235/76
Filed: 1979-07-20
Abstract: Novel-Z-2-Acylamino-3-monosubstituted propenic acids and their esters and salts of the formula <CHEM> wherein R1 is, by preference, hydrogen, lower alkyl or a pharmaceutically acceptable cation, R2 is, by preference, methyl substituted cyclopropyl, (cycloalkyl)alkyl, straight alkyl with more than 4 C-atoms or ramified alkyl and R3 is, by preference, optionally substituted alkyl, are prepared by reacting compounds of the formula     R3-CH2-@-COOR1  with compounds of the formula  R2CONH2  or by acylation of esters of the formula <CHEM>  with an acid chloride     R2@CI  and treating the obtained acylated esters to the formula <CHEM> with t-butylhypochlorite and sodium methoxide, followed by treatment of the resultant intermediate with anhydrous hydrochloric acid. The novel compounds selectively inhibit the metabolism of dipeptidase (E.C.3.4.13.11) and therefore are useful in combination with antibacterial products, by preference with the thienamycin class of compounds.
Patent MA-20150062-A1 (MA)
Title: Composition topique semi-solide contenant de la pirfénidone et de l'oxyde de disulfure dialyle modifié (odd-m) pour éliminer ou prévenir l'acné
Inventor: ARMENDÁRIZ BORUNDA JUAN SOCORRO
IPC: A61P17/10
Filed: 2013-02-27
Abstract: La présente invention concerne une composition topique semi-solide contenant de la pirfénidone et un antimicrobien/antiseptique tel que l'oxyde de sulfure dialyle modifié (odd-m) ainsi que son procédé de fabrication, offrant des avantages par rapport à d'autres formes pharmaceutiques d'administration cutanée connues dans l'art antérieur de la technique, utile en tant qu'agent antifibrotique, anti-inflammatoire et antiseptique pour la prévention, le traitement et la réversion de l'acné et des lésions post-acnéiques. Ladite composition est également utile pour diminuer la couleur rosée de la peau, pour contenir la formation de nouvelles pustules d'acné, pour contenir les pustules d'acné existantes et pour régénérer la peau endommagée après l'acné.
Patent MA-38274-A1 (MA)
Title: Procédé pour l'élaboration d'un agent antitumoral, la 6-(7-((1-amino-cyclo-propyl)-méthoxy)-6- méthoxyquinolin-4-yloxy)-n-méthyl-1-naphthamide, et de sa forme cristalline
Inventor: CHEN GUOQINS PAUL
IPC: A61K31/47
Filed: 2014-01-17
Abstract: L'invention concerne un nouveau procédé permettant de synthétiser la 6-(7-((1-amino- cyclo- propyl)-méthoxy)-6- méthoxyquinolin-4-yloxy)-n-méthyl-1-naphthamide (al3810) par déprotection du benzyl-1-((6-méthoxy-4- (5-(méhylcarbamoyl) naphthalène-2-yloxy) quinolin-7-yloxy)- méthyl) cyclopropyl-carbamate représenté par la formule (i) dans des conditions d'acidité diluée ou faible. L'invention concerne également une forme cristalline stable de la 6-(7-((l-aminocyclo-propyl) -methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide.
Patent MA-39069-A1 (MA)
Title: Dérivé d'urée ou sel pharmacologiquement acceptable de celui-ci
Inventor: TAKAHASHI HIROYASU
IPC: C12N15/09
Filed: 2014-11-27
Abstract: Le problème décrit par la présente invention est de mettre au point un composé qui présente un effet agoniste du récepteur fprl1 (formyl peptide receptor-like 1). La solution selon l'invention porte sur un composé représenté par la formule générale (i) ou un sel pharmacologiquement acceptable de celui-ci. L'invention concerne également une composition pharmaceutique qui comprend ledit composé représenté par la formule (i) ou ledit sel pharmacologiquement acceptable de celui-ci, ainsi que l'utilisation pharmaceutique de celui-ci. (i)
Patent MA-59494-A1 (MA)
Title: Ensemble paroi pour lits catalytiques de réacteurs de synthèse
Inventor: PANZERI NICOLA
IPC: B01J8/02
Filed: 2021-08-09
Abstract: Ensemble perméable aux gaz (10) pour retenir un catalyseur granulaire fin (1) comprenant : une première paroi (2) agencée pour faire face au catalyseur, une seconde paroi espacée de la première paroi (4) et agencée pour être opposée au catalyseur, un noyau de retenue de catalyseur (3) interposé entre ladite première paroi et ladite seconde paroi.
Patent UY-26153-A1 (UY)
Title: Composiciones para tratamiento de suelos, procedimiento para su preparación y su uso
Inventor: LAUDET ALAIN
Filed: 2000-05-19
Abstract: Composición para tratamiento y estabilización de suelos, en particular suelos húmedos, que comprende en la forma de un polvo que tiene un tamano de partícula menor de 2 mm, cal viva y/o aglutinantes hidráulicos a base de calcio, así como también un aditivo no acuoso fluido capaz de aglomerar las partículas más finas de la composición entre sí.
Patent UY-26854-A1 (UY)
Title: Agente terapéutico cristalino
Inventor: HARRIS LAURENCE JAMES
IPC: C07D487/04
Filed: 2001-07-26
Abstract: Un polimorfo de 1- (6- etoxi-5-)3- etil- 6,7 - dihidro-2-(2-metoxietil)-7-oxo-2H- pirazolo (4,3-d), pirimidin -5-el) -3-piridilsulfonil)-4-etilpiperazina.
Patent UY-27309-A1 (UY)
Title: Derivados de quinazolina
Inventor: GOBSON KIETTH HOPKINSON
Filed: 2002-05-27
Abstract: La invención se refiere a derivados de quinazolina de fórmula I, sales del mismo farmacéuticamente aceptables, y procedimientos para su preparación, composiciones que los contienen y la utilización de las propiedades inhibitorias de la tirosinquinasa receptora que presentan dichos compuestos en el tratamiento de enfermedades proliferativas tales como el cáncer.